To ask the Secretary of State for Science, Innovation and Technology, if he will make it his policy to conduct a lessons learned review following the negotiations with AstraZeneca for investment in Speke.
AstraZeneca’s decision not to invest in Speke is deeply disappointing. The Government regularly reviews it’s grant process and routinely seeks applicant feedback. The Government also continues to engage positively with AstraZeneca, including on the new In...
AstraZeneca: Merseyside